Press Room

ATLANTA, GA – April 4, 2022 – As of late Friday evening, the House and Senate respectively p

The Kansas Senate passed Senate Bill 199, which would expand access to inadequate health plans that can avoid patient protections required by federal law.

This Wednesday will mark 12 years since the Affordable Care Act was signed into law and cancer patients, survivors and millions of others gained expanded access to comprehensive health coverage.

This Wednesday will mark 12 years since the Affordable Care Act was signed into law and cancer patients, survivors and millions of others gained expanded access to comprehensive health coverage.

FRANKFORT, KY. – The American Cancer Society Cancer Action Network (ACS CAN) opposes House bill 7, which would require a majority of adults enrolled in Medicaid to meet various work requirements as a condition of eligibility for health care coverage and create a more complex and

CHARLOTTE, NC – February 15, 2022 – In a major shift, breast cancer has surpassed lung cancer as the leading cause of cancer death among Black women as of 2019.

The cost of cancer care is substantially impacting the lives of cancer patients and survivors, forcing them to make significant lifestyle changes, and causing some to incur long-term medical debt.

Cancer patients, survivors and advocates from across the state gathered at the State Capitol on Wednesday to press lawmakers to address several critical issues affecting access to health care for tens of thousands of Kansans, particularly those in need of cancer screening and treatment. The meetings were part of Kansas Cancer Action Day, an annual event organized by the American Cancer Society Cancer Action Network (ACS CAN) to make fighting cancer a legislative prioritity.

American Cancer Society Cancer Action Network (ACS CAN) volunteers from across Arizona rallied at the State Capitol Monday to urge lawmakers to pass legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. Biomarker testing is critical in accessing precision medicine, including targeted therapies that can lead to improved survivorship and better quality of life for cancer patients.

Tonight the House is considering a long-overdue FY2022 funding bill that addresses critical aspects of cancer research, prevention and access to care.